Trends in Antibody-Drug Conjugate Development and Data Management
03/25/2021
Eliot Randle and Joe DiMartino discuss why biopharmaceutical companies are excited about Antibody-Drug Conjugates (ADCs), and how collaborative development is strategically important in ADC research. Read more →